Polycythemia proteins and red blood cell study
Part of Blood & lymphatic clinical trials.
This trial studies proteins and red blood cell production in people with polycythemia (high red blood cell count) to understand its causes. It may help improve care for patients with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults who can agree to participate
- Must have a high red blood cell count: hemoglobin over 16 for women or over 16.5 for men
- The high count must be due to a known cause, like a blood disorder, lung or heart problem, kidney disease, or genetic mutation
- You cannot have had a guardian or be under legal protection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how thick your blood is (blood viscosity) if you have polycythemia, a condition where your body makes too many red blood cells. It aims to understand the relationship between blood thickness and your red blood cell levels.
This study follows people with high red blood cell counts (erythrocytosis) who are seen at a blood specialty clinic. The goal is to track their health over time to learn more about this condition and how it affects patients.
This study looks at people who have higher-than-normal hemoglobin and platelet counts. It aims to better understand the biology behind these blood changes and how they may be related to disease.
This study tests whether lisinopril, a common blood pressure medication, can help lower red blood cell counts in people who have elevated hemoglobin levels. Researchers want to see if this drug could offer a simpler treatment option for this condition.
This study tests whether CPAP therapy (a machine that helps keep your airway open while you sleep) can lower high red blood cell counts in people who have both sleep apnea and polycythemia. It may help reduce the need for other treatments.
This trial tests a new medicine (NANOKINE) that helps your body make red blood cells, compared to a well-known drug (Eprex). It is for healthy men to see how safe it is and how it works in the body. If you qualify, you might help develop a better option for treating anemia.
Hear when a new Erythropoiesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.